Study of Taxus Stent in Women Shows Positive Outcomes

Boston Scientific announced results from its TAXUS WOMAN study, a gender-specific analysis assessing the efficacy data of the Taxus paclitaxel-eluting stent in women undergoing coronary revascularization.

The study found paclitaxel-eluting stents to have similar clinical outcomes in women and men, despite the higher risk profile in women patients, the company said.

“Previous trials and registries have demonstrated a less favorable clinical outcome in women compared to men when undergoing coronary revascularization with bare-metal stents,” Ghada Mikhail, consultant cardiologist at St. Mary’s Hospital Trust, said.

“These data show, however, that the Taxus paclitaxel-eluting coronary stent works equally well in women, maintaining its anti-restenotic efficacy advantages and positive safety profile relative to bare-metal stents,” she said.